Literature DB >> 28231054

Alzheimer's disease as an inflammatory disease.

Marta Bolós1,2, Juan Ramón Perea1,2, Jesús Avila1,2.   

Abstract

Alzheimer's disease (AD) is a neurodegenerative condition characterized by the formation of amyloid-β plaques, aggregated and hyperphosphorylated tau protein, activated microglia and neuronal cell death, ultimately leading to progressive dementia. In this short review, we focus on neuroinflammation in AD. Specifically, we describe the participation of microglia, as well as other factors that may contribute to inflammation, in neurodegeneration.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28231054     DOI: 10.1515/bmc-2016-0029

Source DB:  PubMed          Journal:  Biomol Concepts        ISSN: 1868-5021


  63 in total

1.  RIPK1 promotes inflammation and β-amyloid accumulation in Alzheimer's disease.

Authors:  David C Rubinsztein
Journal:  Proc Natl Acad Sci U S A       Date:  2017-10-02       Impact factor: 11.205

Review 2.  Lipoprotein-associated phospholipase A2: The story continues.

Authors:  Fubao Huang; Kai Wang; Jianhua Shen
Journal:  Med Res Rev       Date:  2019-05-29       Impact factor: 12.944

3.  Roflumilast ameliorates cognitive impairment in APP/PS1 mice via cAMP/CREB/BDNF signaling and anti-neuroinflammatory effects.

Authors:  Huancun Feng; Canmao Wang; Wei He; Xinjun Wu; Shujie Li; Zhenkun Zeng; Meidan Wei; Binghong He
Journal:  Metab Brain Dis       Date:  2019-01-04       Impact factor: 3.584

4.  Network-based analysis on genetic variants reveals the immunological mechanism underlying Alzheimer's disease.

Authors:  Pan Guo; Changying Cao; Yuequn Ma; Ju Wang
Journal:  J Neural Transm (Vienna)       Date:  2021-04-28       Impact factor: 3.575

Review 5.  Brain Injury-Mediated Neuroinflammatory Response and Alzheimer's Disease.

Authors:  Duraisamy Kempuraj; Mohammad Ejaz Ahmed; Govindhasamy Pushpavathi Selvakumar; Ramasamy Thangavel; Arshdeep S Dhaliwal; Iuliia Dubova; Shireen Mentor; Keerthivaas Premkumar; Daniyal Saeed; Haris Zahoor; Sudhanshu P Raikwar; Smita Zaheer; Shankar S Iyer; Asgar Zaheer
Journal:  Neuroscientist       Date:  2019-05-16       Impact factor: 7.519

6.  Does HIV infection contribute to increased beta-amyloid synthesis and plaque formation leading to neurodegeneration and Alzheimer's disease?

Authors:  Tamas Fulop; Jacek M Witkowski; Anis Larbi; Abdelouahed Khalil; Georges Herbein; Eric H Frost
Journal:  J Neurovirol       Date:  2019-03-13       Impact factor: 2.643

7.  The distinct structural preferences of tau protein repeat domains.

Authors:  Xuhua Li; Xuewei Dong; Guanghong Wei; Martin Margittai; Ruth Nussinov; Buyong Ma
Journal:  Chem Commun (Camb)       Date:  2018-05-31       Impact factor: 6.222

Review 8.  Targeting Impaired Antimicrobial Immunity in the Brain for the Treatment of Alzheimer's Disease.

Authors:  Tamas Fulop; Shreyansh Tripathi; Serafim Rodrigues; Mathieu Desroches; Ton Bunt; Arnold Eiser; Francois Bernier; Pascale B Beauregard; Annelise E Barron; Abdelouahed Khalil; Adam Plotka; Katsuiku Hirokawa; Anis Larbi; Christian Bocti; Benoit Laurent; Eric H Frost; Jacek M Witkowski
Journal:  Neuropsychiatr Dis Treat       Date:  2021-05-04       Impact factor: 2.570

9.  The Application of Convolutional Neural Network Model in Diagnosis and Nursing of MR Imaging in Alzheimer's Disease.

Authors:  Xiaoxiao Chen; Linghui Li; Ashutosh Sharma; Gaurav Dhiman; S Vimal
Journal:  Interdiscip Sci       Date:  2021-07-05       Impact factor: 2.233

Review 10.  Systemic Actions of SGLT2 Inhibition on Chronic mTOR Activation as a Shared Pathogenic Mechanism between Alzheimer's Disease and Diabetes.

Authors:  Gabriela Dumitrita Stanciu; Razvan Nicolae Rusu; Veronica Bild; Leontina Elena Filipiuc; Bogdan-Ionel Tamba; Daniela Carmen Ababei
Journal:  Biomedicines       Date:  2021-05-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.